The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Penpulimab plus anlotinib as second-line treatment for the small cell lung cancer after failure of platinum-based systemic chemotherapy.
 
Changgong Zhang
No Relationships to Disclose
 
Sheng Yang
No Relationships to Disclose
 
Jianhua Chen
No Relationships to Disclose
 
Huijuan Wu
No Relationships to Disclose
 
Jun Wang
No Relationships to Disclose
 
Yingping Li
No Relationships to Disclose
 
Liying Gao
No Relationships to Disclose
 
Zhongyao Jia
No Relationships to Disclose
 
Yan Sun
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Xin Lin Mu
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Kailiang Wu
No Relationships to Disclose
 
Qiang Liu
No Relationships to Disclose
 
Xiaoping Jin
Employment - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Xiaowen Tan
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose